Business
What’s going on with the Mesoblast (ASX:MSB) share price in 2020?
The Mesoblast limited (ASX: MSB) share price has had an incredibly eventful year.
The stem cell-focused biotech company’s shares have been as high as $5.70 and as low as $1.02.
Today, the Mesoblast share price sits at $2.40 after crashing over 40% lower last week.
What is happening with the Mesoblast share price?
Mesoblast has been extremely busy this year with a number of key trials and applications.
This includes running a trial for remestemcel-L in the treatment of COVID-19 Acute Respiratory Distress Syndrome (ARDS), an application for remestemcel-L to treat paediatric patients with steroid-refractory acute graft versus host disease (SR-aGvHD), and a trial of rexlemestrocel-L in patients with advanced chronic heart…
-
Business23 hours agoThe best ASX ETFs to buy for long-term wealth building
-
Business15 hours agoAged 30 and earning an average wage? You’re now set up for retirement. Here’s how
-
General21 hours agoAustralia’s mental health plan ‘not fit for purpose’ and must be re-designed, new report finds
-
Noosa News19 hours agoAssault charges, Nambour – Sunshine Coast